Challenges and Opportunities in the Process Development of Chimeric Vaccines.

Area of Science:

• Biotechnology
• Vaccinology
• Process Engineering

Background:

• Conventional vaccines face limitations including inefficiency, safety concerns, and inability to address genetic variability in pathogens.
• Chimeric vaccines, combining multiple antigen genes, are being developed to protect against rapidly evolving, drug-resistant microbes.
• The need for economical and rapidly deployable vaccines for large populations drives innovation.

Purpose of the Study:

• To review the challenges and emerging strategies in the bioprocess development of chimeric vaccines.
• To highlight the role of advanced technologies in optimizing chimeric vaccine production.
• To discuss the potential of chimeric vaccines in addressing global health threats.

Main Methods:

• Computational omics-based approaches for chimeric vaccine design.
• Optimization of upstream and downstream bioprocessing for industrial-scale manufacturing.
• Application of high-throughput process technologies, including PAT, QbD, and DoE.
• Integration of modeling, simulation, single-use technology, and continuous bioprocessing.

Main Results:

• Advanced bioprocess technologies facilitate convenient and economical scalable production of complex vaccines.
• High-throughput tools and integrated continuous bioprocessing address challenges in manufacturing evolving pathogen vaccines.
• Quality-by-Design (QbD) and Process Analytical Technology (PAT) enhance process understanding and control.

Conclusions:

• Bioprocess development for chimeric vaccines is critical for addressing global health challenges.
• Innovative strategies and advanced technologies are essential for efficient and scalable vaccine production.
• The review provides insights into overcoming hurdles in developing next-generation vaccines.